Generation and characterisation of C-terminally stabilised PYY molecules with potential in vivo NPYR2 activity

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
13 Downloads (Pure)

Abstract

Background:
Activation of neuropeptide Y2 receptors (NPYR2) by the N-terminally truncated, dipeptidyl peptidase-4 (DPP-4) generated, Peptide YY (PYY) metabolite, namely PYY(3-36), results in satiating actions. However, PYY(3-36) is also subject to C-terminal enzymatic cleavage, which annuls anorectic effects.
Methods:
Substitution of L-Arg35 with D-Arg35 in the DPP-4 stable sea lamprey PYY(1-36) peptide imparts full C-terminal stability. In the current study, we have taken this molecule and introduced DPP-4 susceptibility by Iso3 substitution.
Results:
As expected, [Iso3]sea lamprey PYY(1-36) and [Iso3](D-Arg35)sea lamprey PYY(1-36) were N-terminally degraded to respective PYY(3-36) metabolites in plasma. Only [Iso3](D-Arg35)sea lamprey PYY(1-36) was C-terminally stable. Both peptides possessed similar insulinostatic and anti-apoptotic biological actions to native PYY(1-36) in beta-cells. Unlike native PYY(1-36) and [Iso3](D-Arg35)sea lamprey PYY(1-36), [Iso3]sea lamprey PYY(1-36) displayed some proliferative actions in Npyr1 knockout beta-cells. In addition, [Iso3]sea lamprey PYY(1-36) induced more rapid NPYR2-dependent appetite suppressive effects in mice than its C-terminally stable counterpart. Twice daily administration of either peptide to high fat fed (HFF) mice resulted in significant body weight reduction and improvements in circulating triglyceride levels. [Iso3]sea lamprey PYY(1-36) treatment also prevented elevations in glucagon. Both peptides, and especially [Iso3]sea lamprey PYY(1-36), improved glucose tolerance. The treatment interventions also partially reversed the deleterious effects of sustained high fat feeding on pancreatic islet morphology.
Conclusion:
The present study confirms that sustained NPYR2 receptor activation by [Iso3](D-Arg35)sea lamprey induced significant weight lowering actions. However, identifiable benefits of this peptide over [Iso3]sea lamprey PYY(1-36), which was not protected against C-terminal degradation, were not pronounced.
Original languageEnglish
Article number154339
JournalMetabolism
Volume111
Early online date7 Aug 2020
DOIs
Publication statusPublished (in print/issue) - 1 Oct 2020

Keywords

  • Appetite suppression
  • Degradation
  • Peptide YY (PYY)
  • Sea lamprey

Fingerprint

Dive into the research topics of 'Generation and characterisation of C-terminally stabilised PYY molecules with potential in vivo NPYR2 activity'. Together they form a unique fingerprint.

Cite this